Mirabella Financial Services LLP acquired a new stake in Zoetis Inc. (NYSE:ZTS – Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund acquired 60,803 shares of the company’s stock, valued at approximately $11,880,000.
A number of other institutional investors and hedge funds also recently bought and sold shares of ZTS. Darwin Wealth Management LLC bought a new position in shares of Zoetis in the third quarter valued at about $31,000. First Personal Financial Services acquired a new stake in Zoetis in the 3rd quarter valued at about $33,000. Capital Performance Advisors LLP bought a new position in shares of Zoetis in the third quarter worth about $33,000. Quarry LP lifted its position in shares of Zoetis by 273.2% during the second quarter. Quarry LP now owns 209 shares of the company’s stock worth $36,000 after purchasing an additional 153 shares in the last quarter. Finally, LRI Investments LLC bought a new stake in shares of Zoetis during the first quarter valued at approximately $43,000. Institutional investors and hedge funds own 92.80% of the company’s stock.
Analysts Set New Price Targets
Several research analysts recently weighed in on ZTS shares. Stifel Nicolaus boosted their price objective on shares of Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a research report on Wednesday, September 18th. Piper Sandler upped their price target on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 14th. Argus upgraded Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. BTIG Research raised their target price on shares of Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, August 12th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Ten analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Zoetis presently has an average rating of “Buy” and an average price target of $221.44.
Zoetis Stock Up 0.1 %
Zoetis stock opened at $176.96 on Monday. The company has a 50 day moving average of $185.62 and a 200-day moving average of $180.72. The stock has a market capitalization of $79.84 billion, a PE ratio of 33.26, a price-to-earnings-growth ratio of 2.71 and a beta of 0.90. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $201.92.
Zoetis (NYSE:ZTS – Get Free Report) last announced its earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, topping the consensus estimate of $1.46 by $0.12. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The business had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.29 billion. During the same quarter in the prior year, the company posted $1.36 earnings per share. The firm’s revenue was up 11.6% on a year-over-year basis. On average, equities research analysts anticipate that Zoetis Inc. will post 5.9 EPS for the current fiscal year.
Zoetis Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be issued a dividend of $0.432 per share. The ex-dividend date of this dividend is Thursday, October 31st. This represents a $1.73 annualized dividend and a yield of 0.98%. Zoetis’s payout ratio is presently 32.52%.
Zoetis Profile
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
See Also
- Five stocks we like better than Zoetis
- How Can Investors Benefit From After-Hours Trading
- 3 Strategic ETFs for Bearish Investors Post-Election
- What is a support level?
- Super Micro’s Stock Price Is Ready to Rebound After Market Reset
- Retail Stocks Investing, Explained
- 3 Forces Shaping a Bullish 2025 Outlook
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.